The final day of 2025 Formula 1 pre-season testing concluded on Friday at the Sakhir Circuit in Bahrain. Running was split ...

Novartis (NYSE:NVS) announced Friday that the European Medicines Agency (EMA), endorsed Fabhalta for the treatment of adults ...

C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that C3 AI Chairman and CEO Thomas M.

A new study highlights the importance of normal serology in reducing severe and renal flares in systemic lupus erythematosus ...

If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 Phase ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

C3.ai, Inc. (AI) stock plunged nearly 10% on Thursday despite the enterprise artificial intelligence software applications ...

Take a deeper look into F1 testing and compare how McLaren, Mercedes, and Ferrari are looking heading into the 2025 season.

Apple's new 'e' series smartphone could be a regular thing: new iPhone 16e would be followed up by iPhone 17e in 2026 with in ...

Many car manufacturers find it extremely difficult to come up with an affordable small electric car. The first European ...

Health officials in Rock County are advising people that the best protection against measles infection is to get a measles ...

After a productive second day in Bahrain, seven-time world champion Lewis Hamilton insisted that he is slowly "eking out a little bit more each time" he heads out on the Bahrain track with his SF-25.